ECMO Hemostatic Transfusions in Children (ECSTATIC)
Sponsor: Children's Hospital and Health System Foundation, Wisconsin
Listed as NCT05796557, this PHASE4 trial focuses on Extracorporeal Membrane Oxygenation Complication and Hemorrhage and remains completed. Sponsored by Children's Hospital and Health System Foundation, Wisconsin, it has been updated 11 times since 2023, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Jun 2025 — Sep 2025 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Feb 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Dec 2024 — Feb 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE4
▶ Show 6 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Mar 2024 — Jun 2024 [monthly]
Recruiting PHASE4
-
Dec 2023 — Mar 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Aug 2023 — Dec 2023 [monthly]
Not Yet Recruiting PHASE4
-
May 2023 — Aug 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital and Health System Foundation, Wisconsin
- Columbia University
- Duke University
- Emory University
- Johns Hopkins All Children's Hospital
- National Heart, Lung, and Blood Institute (NHLBI)
- Schneider Medical Children's Center, Israel
- University of Iowa
- University of Rochester
- University of Utah
- Virginia Commonwealth University
- Weill Medical College of Cornell University
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .